Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Corticosteroids protect infected cells against mycobacterial killing in vitro.

Tükenmez H, Edström I, Kalsum S, Braian C, Ummanni R, Fick SB, Sundin C, Lerm M, Elofsson M, Larsson C.

Biochem Biophys Res Commun. 2019 Mar 26;511(1):117-121. doi: 10.1016/j.bbrc.2019.02.044. Epub 2019 Feb 14.

2.

Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening.

Tükenmez H, Edström I, Ummanni R, Fick SB, Sundin C, Elofsson M, Larsson C.

Sci Rep. 2019 Jan 10;9(1):26. doi: 10.1038/s41598-018-37176-4.

3.

Implementation of an Oxytocin Checklist to Improve Clinical Outcomes.

Sundin C, Mazac L, Ellis K, Garbo C.

MCN Am J Matern Child Nurs. 2018 May/Jun;43(3):133-138. doi: 10.1097/NMC.0000000000000428.

PMID:
29489527
4.

Posterior Reversible Encephalopathy Syndrome.

Sundin CS, Johnson ML.

MCN Am J Matern Child Nurs. 2018 Mar/Apr;43(2):77-82. doi: 10.1097/NMC.0000000000000409.

PMID:
29470266
5.

Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity.

Saleeb M, Sundin C, Aglar Ö, Pinto AF, Ebrahimi M, Forsberg Å, Schüler H, Elofsson M.

Eur J Med Chem. 2018 Jan 1;143:568-576. doi: 10.1016/j.ejmech.2017.11.036. Epub 2017 Nov 21.

6.

The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.

Uusitalo P, Hägglund U, Rhöös E, Scherman Norberg H, Elofsson M, Sundin C.

J Antibiot (Tokyo). 2017 Aug;70(9):937-943. doi: 10.1038/ja.2017.64. Epub 2017 Jun 7.

PMID:
28588224
7.

Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.

Anantharajah A, Buyck JM, Sundin C, Tulkens PM, Mingeot-Leclercq MP, Van Bambeke F.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02566-16. doi: 10.1128/AAC.02566-16. Print 2017 Jun.

8.

Amniotic Fluid Embolism.

Sundin CS, Mazac LB.

MCN Am J Matern Child Nurs. 2017 Jan/Feb;42(1):29-35.

PMID:
27755062
9.

Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.

Anantharajah A, Faure E, Buyck JM, Sundin C, Lindmark T, Mecsas J, Yahr TL, Tulkens PM, Mingeot-Leclercq MP, Guery B, Van Bambeke F.

J Infect Dis. 2016 Oct 1;214(7):1105-16. doi: 10.1093/infdis/jiw295. Epub 2016 Jul 13.

PMID:
27412581
10.

Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns.

Ederth J, Jern C, Norder H, Magnius L, Alm E, Rognsvåg BK, Sundin CG, Brytting M, Esbjörnsson J, Mild M.

Infect Ecol Epidemiol. 2016 Feb 5;6:30670. doi: 10.3402/iee.v6.30670. eCollection 2016.

11.

Implementing Skin-to-Skin Care in the Operating Room After Cesarean Birth.

Sundin CS, Mazac LB.

MCN Am J Matern Child Nurs. 2015 Jul-Aug;40(4):249-55. doi: 10.1097/NMC.0000000000000142.

PMID:
26121756
12.

Self-sampling for analysis of respiratory viruses in a large-scale epidemiological study in Sweden.

Plymoth A, Rotzen-Ostlund M, Zweygberg-Wirgart B, Sundin CG, Ploner A, Nyren O, Linde A.

Euro Surveill. 2015 Mar 19;20(11). pii: 21063.

13.

Solving the supply of resveratrol tetramers from Papua New Guinean rainforest anisoptera species that inhibit bacterial type III secretion systems.

Davis RA, Beattie KD, Xu M, Yang X, Yin S, Holla H, Healy PC, Sykes M, Shelper T, Avery VM, Elofsson M, Sundin C, Quinn RJ.

J Nat Prod. 2014 Dec 26;77(12):2633-40. doi: 10.1021/np500433z. Epub 2014 Nov 18.

PMID:
25405587
14.

Peripartum cardiomyopathy.

Sundin CS.

MCN Am J Matern Child Nurs. 2014 Jul-Aug;39(4):220-4. doi: 10.1097/NMC.0000000000000058.

PMID:
24978000
15.

The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.

Zetterström CE, Hasselgren J, Salin O, Davis RA, Quinn RJ, Sundin C, Elofsson M.

PLoS One. 2013 Dec 4;8(12):e81969. doi: 10.1371/journal.pone.0081969. eCollection 2013.

16.

Derivatives of 8-hydroxyquinoline--antibacterial agents that target intra- and extracellular Gram-negative pathogens.

Enquist PA, Gylfe A, Hägglund U, Lindström P, Norberg-Scherman H, Sundin C, Elofsson M.

Bioorg Med Chem Lett. 2012 May 15;22(10):3550-3. doi: 10.1016/j.bmcl.2012.03.096. Epub 2012 Apr 6.

PMID:
22525317
17.

Pseudoceramines A-D, new antibacterial bromotyrosine alkaloids from the marine sponge Pseudoceratina sp.

Yin S, Davis RA, Shelper T, Sykes ML, Avery VM, Elofsson M, Sundin C, Quinn RJ.

Org Biomol Chem. 2011 Oct 7;9(19):6755-60. doi: 10.1039/c1ob05581j. Epub 2011 Aug 17.

PMID:
21850326
18.

[Clothes in health care. Don't mix identification and hygiene routines].

Tammelin A, Karell AC, Kriisa M, Aspevall O, Nilsson P, Qvarfordt I, Iversen KU, Andersson R, Ahrén C, Melander E, Fraenkel CJ, Lytsy B, Isaksson B, Samuelsson A, Lundholm R, Johansson A, Norén T, Ripa T, Karlsson L, Löfgren S, Matussek A, Wahlberg T, Oberg S, Eliasson I, Sundin CG, Andersson E, Granström R, Danielsson A, Lindblom A, Ryding U, Blad L, Boman H, Karlman K, Heimer D, Hambraeus A, Ransjö U.

Lakartidningen. 2011 Mar 2-8;108(9):453. Swedish. No abstract available.

PMID:
21744609
19.

[Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms].

Sundin C, Elofsson M, Wolf-Watz H, Rosell S.

Lakartidningen. 2009 Sep 30-Oct 6;106(40):2543-5. Review. Swedish. No abstract available.

PMID:
19908625
20.

Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton.

Veenendaal AK, Sundin C, Blocker AJ.

J Bacteriol. 2009 Jan;191(2):563-70. doi: 10.1128/JB.01004-08. Epub 2008 Nov 7.

21.

Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides.

Kauppi AM, Andersson CD, Norberg HA, Sundin C, Linusson A, Elofsson M.

Bioorg Med Chem. 2007 Nov 15;15(22):6994-7011. Epub 2007 Aug 22.

PMID:
17851084
22.

Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle.

Bailey L, Gylfe A, Sundin C, Muschiol S, Elofsson M, Nordström P, Henriques-Normark B, Lugert R, Waldenström A, Wolf-Watz H, Bergström S.

FEBS Lett. 2007 Feb 20;581(4):587-95. Epub 2007 Jan 17.

23.

A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Muschiol S, Bailey L, Gylfe A, Sundin C, Hultenby K, Bergström S, Elofsson M, Wolf-Watz H, Normark S, Henriques-Normark B.

Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14566-71. Epub 2006 Sep 14.

24.

Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN.

Sundin C, Thelaus J, Bröms JE, Forsberg A.

Microb Pathog. 2004 Dec;37(6):313-22. Epub 2004 Dec 8.

PMID:
15619427
25.
26.

Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa.

Bröms JE, Sundin C, Francis MS, Forsberg A.

J Infect Dis. 2003 Jul 15;188(2):239-49. Epub 2003 Jul 1.

PMID:
12854079
27.

Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa.

Sundin C, Wolfgang MC, Lory S, Forsberg A, Frithz-Lindsten E.

Microb Pathog. 2002 Dec;33(6):265-77.

PMID:
12495673
28.

Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.

Henriksson ML, Sundin C, Jansson AL, Forsberg A, Palmer RH, Hallberg B.

Biochem J. 2002 Nov 1;367(Pt 3):617-28.

29.

Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction.

Sundin C, Henriksson ML, Hallberg B, Forsberg A, Frithz-Lindsten E.

Cell Microbiol. 2001 Apr;3(4):237-46.

PMID:
11298647
30.

[Lung roentgen can be eliminated following uncomplicated pneumonia].

Sundin CG, Strömberg A.

Nord Med. 1991;106(2):48-9. Swedish.

PMID:
2006093
31.

Diagnosis of whooping cough--a comparison of culture, immunofluorescence and serology with ELISA.

Håkansson S, Sundin CG, Granström M, Gästrin B.

Scand J Infect Dis. 1984;16(3):281-4.

PMID:
6149614

Supplemental Content

Loading ...
Support Center